Accenture plc financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Accenture plc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	36,177	40,993	43,215	44,327	50,533	61,594	64,112	64,896	69,673	74,183
Cost of revenue	25,105	28,499	29,900	30,351	34,169	41,893	43,380	43,734	47,438	50,408
Gross profit	11,071	12,493	13,315	13,976	16,364	19,702	20,732	21,162	22,235	23,776
Research and development	704	791	800	871	1,118	1,123	1,299	1,150	817	1,011
Selling and marketing	3,752	4,196	4,447	4,626	5,288	6,108	6,583	6,847	7,043	7,243
General and administrative	2,128	2,398	2,562	2,837	3,454	4,226	4,276	4,281	4,351	4,819
Operating income	5,191	5,899	6,305	6,514	7,622	9,367	8,810	9,596	10,226	11,406
Interest expense	15.5	19.5	23	33.1	59.5	47.3	47.5	59	229	303
Interest income	37.9	56.3	87.5	69.3	33.4	45.1	280	272	336	363
Other non-operating income	-87.7	-127	-118	224	166	-72.5	96.6	-110	-63	-93.6
Pre-tax income	4,616	5,808	6,252	6,774	7,761	9,196	9,139	9,699	10,270	11,372
Income tax	981	1,593	1,406	1,589	1,771	2,207	2,136	2,280	2,438	2,849
Net income	3,445	4,060	4,779	5,108	5,907	6,877	6,872	7,265	7,678	8,367
EBITDA	5,993	6,826	7,198	7,536	8,749	10,686	10,222	11,039	10,848	11,986
EPS, basic	5.56	6.46	7.49	8.03	9.31	10.87	10.90	11.57	12.29	13.66
EPS, diluted	5.44	6.34	7.36	7.89	9.16	10.71	10.77	11.44	12.15	13.56
Shares, basic (weighted)	620	628	638	636	635	633	631	628	625	612
Shares, diluted (weighted)	660	655	650	648	646	643	639	636	632	617
Dividend per share	2.42	2.66	2.92	3.20	3.52	3.88	4.48	5.16	5.92

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	4,127	5,061	6,127	8,415	8,168	7,890	9,045	5,004	11,479	12,831
Short-term investments	3.01	3.19	3.31	94.3	4.29	3.97	4.58	5.4	5.95	6.3
Receivables	4,569	4,996	7,467	7,192	8,797	10,484	10,691	11,873	13,065	14,216
Other current assets	1,082	1,025	1,225	1,393	1,766	1,940	2,105	2,183	2,431	2,665
Total current assets	12,097	13,586	15,451	17,750	19,667	21,611	23,382	20,858	28,901	31,831
Property, plant and equipment	1,141	1,264	1,391	1,546	1,639	1,659	1,530	1,521	1,566	1,722
Lease right-of-use assets			0	3,183	3,183	3,019	2,637	2,757	2,740	3,006
Goodwill	5,002	5,383	6,206	7,710	11,126	13,133	15,573	21,120	22,536	26,819
Intangible assets	710	687	841	1,029	1,711	1,931	2,073	2,904	2,411	2,907
Long-term investments	212	216	240	325	330	318	197	335	721	940
Other non-current assets	1,226	1,186	1,400	1,646	2,455	2,668	739	1,307	1,522	1,474
Total assets	22,690	24,449	29,790	37,079	43,176	47,263	51,245	55,932	65,395	73,598
Accounts payable	1,525	1,349	1,647	1,350	2,274	2,559	2,491	2,744	2,696	3,003
Accrued liabilities	4,060	4,569	4,891	5,084	6,748	7,612	7,506	7,051	8,084	9,228
Deferred revenue	2,670	2,838	3,189	3,637	4,229	4,478	4,907	5,175	6,073	6,277
Short-term debt	2.91	5.34	6.41	7.82	12.1	9.18	105	946	114	113
Total current liabilities	9,824	10,152	11,062	12,663	15,709	17,523	18,009	18,976	20,352	22,304
Long-term debt	22.2	19.7	16.2	54.1	53.5	45.9	43.1	78.6	5,034	9,999
Lease liabilities			0	2,668	2,697	2,563	2,311	2,369	2,305	2,517
Other non-current liabilities	349	442	527	534	554	462	465	939	1,198	1,213
Total liabilities	12,980	13,724	14,962	19,579	23,079	24,516	24,787	26,764	33,154	40,873
Total debt	22.2	19.7	16.2	54.1	53.5	45.9	43.1	78.6	5,034	9,999
Paid-in capital	3,516	4,871	5,804	7,167	8,618	10,679	12,779	14,711	16,603	19,357
Retained earnings	7,082	7,952	10,422	12,376	13,989	18,204	19,316	23,082	21,019	24,939
Treasury stock	-1,649	-2,117	-1,388	-2,566	-3,408	-6,678	-7,063	-10,565	-7,752	-14,166
Other comprehensive income	-1,095	-1,576	-1,841	-1,562	-1,419	-2,190	-1,743	-1,555	-1,465	-1,375
Shareholders' equity	8,949	10,365	14,409	17,001	19,529	22,106	25,693	28,289	31,195	31,567
Minority interests	761	360	419	499	568	641	766	880	1,046	1,157
Total equity	9,710	10,725	14,828	17,499	20,097	22,747	26,459	29,168	32,241	32,724
Total liabilities and equity	22,690	24,449	29,790	37,079	43,176	47,263	51,245	55,932	65,395	73,598

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	3,445	4,060	4,779	5,108	5,907	6,877	6,872	7,265	7,678	8,367
Depreciation and amortization	802	927	893	1,022	1,128	1,319	1,412	1,443	622	581
Stock-based compensation	795	977	1,093	1,198	1,343	1,680	1,913	1,942	2,094	2,100
Deferred income tax	-364	94	-96.4	171	60.9	-213	-269	-94	357	125
Change in receivables	-73.3	-711	-526	722	-1,472	-2,412	87.7	-602	-1,021	-1,282
Change in payables	174	-168	177	-360	825	374	-171	46.5	-111	270
Cash from operations	4,973	6,027	6,627	8,215	8,975	9,541	9,524	9,131	11,474	12,363
Capital expenditures	-516	-619	-599	-599	-580	-718	-528	-517	-600	-743
Acquisitions	-1,704	-658	-1,193	-1,532
Cash from investing	-2,234	-1,250	-1,756	-1,895	-4,310	-4,261	-2,622	-7,062	-2,020	-5,637
Debt issued						0	100	1,599	5,061	4,979
Debt repaid						0	0	-771	-932	0
Share buybacks	-2,649	-2,639	-2,691	-2,916	-3,703	-4,116	-4,330	-4,525	-4,619	-7,521
Dividends paid	-1,568	-1,709	-1,864	-2,038	-2,236	-2,457	-2,827	-3,241	-3,700	-3,987
Cash from financing	-3,560	-3,709	-3,767	-4,049	-4,926	-5,311	-5,645	-6,064	-2,948	-5,314
Exchange rate effect	42.3	-134	-38.7	16.9	13.8	-248	-101	-46.3	-32.2	-59.4
Net change in cash	-779	935	1,065	2,288	-247	-278	1,155	-4,041	6,474	1,353
Free cash flow	4,457	5,408	6,028	7,616	8,395	8,823	8,996	8,615	10,874	11,621
Interest paid	15.8	19.7	22.6	28.5	36.1	46	46.5	37.2	155	266
Income taxes paid	1,289	1,373	1,587	1,360	1,567	1,779	2,316	2,387	2,472	2,638

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $258.51 on November 10, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	32.0%	Gross profit / revenue.
Operating margin	15.4%	Operating income / revenue.
EBITDA margin	16.2%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	15.3%	Pre-tax income / revenue.
Net margin	11.3%	Net income / revenue.
FCF margin	15.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	16.7%	Cash from operations / revenue.
Effective tax rate	25.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	26.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	12.0%	Net income / average total assets.
Return on invested capital (ROIC)	32.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	1.4%	Research and development expense / revenue.
Stock-based pay / revenue	2.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.0%	Capital expenditures / revenue.
D&A / revenue	0.8%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	6.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	5.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	8.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	6.9%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	4.7%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	7.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	11.5%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	9.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	8.4%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	10.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	5.5%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	6.5%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	9.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	6.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	7.2%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	11.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	8.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	8.2%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	7.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	9.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	6.6%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	6.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	8.9%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	6.7%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	1.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	7.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	10.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	12.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	12.8%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	11.3%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-2.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.9%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.43x	Current assets / current liabilities.
Quick ratio	1.21x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.58x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.32x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	13.6%	Total debt / total assets.
Liabilities / assets	55.5%	Total liabilities / total assets.
Net debt	-$2.84B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-0.24x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	37.6x	Operating income / interest expense.
Working capital	$9.53B	Current assets - current liabilities.
Goodwill and intangibles / assets	40.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	$1.84B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.07x	Revenue / average total assets.
Fixed asset turnover	45.1x	Revenue / average property, plant and equipment.
Receivables turnover	5.44x	Revenue / average receivables.
Days sales outstanding	67 days	365 x average receivables / revenue.
Days payables	21 days	365 x average accounts payable / cost of revenue.
FCF conversion	138.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	6.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$13.56	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$13.66	Net income per basic share, as reported (split-adjusted).
Revenue per share	$120.14	Revenue / diluted weighted shares.
FCF per share	$18.82	Free cash flow / diluted weighted shares.
Operating cash flow per share	$20.02	Cash from operations / diluted weighted shares.
Book value per share	$51.12	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$2.98	Tangible book value / shares outstanding.
Cash per share	$20.79	(Cash + short-term investments) / shares outstanding.
Payout ratio	47.7%	Dividends paid / net income, when net income is positive.
Dividends / FCF	34.3%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	64.7%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$172.56B	Share price x shares outstanding.
Enterprise value	$169.72B	Market cap + total debt - cash - short-term investments.
P/E	20.6x	Market cap / net income. Only when net income is positive.
P/S	2.33x	Market cap / revenue.
P/B	5.47x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	93.7x	Market cap / tangible book value, when positive.
P/FCF	14.8x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	14.0x	Market cap / cash from operations, when positive.
EV/Sales	2.29x	Enterprise value / revenue.
EV/EBIT	14.9x	Enterprise value / operating income, when both are positive.
EV/EBITDA	14.2x	Enterprise value / EBITDA, when both are positive.
EV/FCF	14.6x	Enterprise value / free cash flow, when both are positive.
FCF yield	6.7%	Free cash flow / market cap.
Earnings yield	4.8%	Net income / market cap (the inverse of P/E).
Dividend yield	2.3%	Dividends paid over the period / market cap.
Shareholder yield	6.7%	(Dividends paid + share buybacks) / market cap.
PEG	2.58x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Accenture plc's revenue in fiscal 2026?

Accenture plc reported revenue of $74.18B for fiscal 2026, 6.5% higher than the year before.

Was Accenture plc profitable in fiscal 2026?

Yes. Net income was $8.37B, a net margin of 11.3%.

How much free cash flow did Accenture plc generate in fiscal 2026?

Cash from operations of $12.36B minus capital expenditures of $742.7M left free cash flow of $11.62B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Accenture plc